Qloudlab developed a new tool for people undergoing anticoagulant treatment.

Qloudlab, a startup based in the microengineering laboratory at the Swiss Federal Institute of Technology or EPFL, has developed a diagnostic tool that uses a smartphone screen to perform blood tests.

The diagnostic tool was developed for people undergoing anticoagulant treatment. One of the effects of anticoagulants is to limit the formation of blood clots in arteries, veins, and the heart – clots that can block the blood vessels, hinder the flow of oxygen and increase the risk of a stroke or heart attack. Anticoagulant treatment requires patients to undergo regular blood flow monitoring, usually done at a clinic or hospital. Qloudlab's diagnostic tool allows patients to do the tests themselves in their own home.

READ THIS ARTICLE FOR $15
$15 provides access to this article and every case-study, interview, and analysis piece that we publish for the next 30 days. Our Premium Subscription also provides access to a database of over 100,000 articles on innovation in brand, customer, and retail experience.
Already a subscriber? Log in